Return On Asset ratio Analysis of MedTech Acquisition Corp - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY ROA
Period Ending - Dec-22
Excellent ROA
27.44
Period Ending - Dec-21
Poor ROA
1.89
Growth
1350.44 %
Trailing Twelve Months ROA
Period Ending - Dec-22
Not Good ROA
3.69
Most recent Quarter ROA
Period Ending - Jun-23
Very Poor ROA
-8.13
ROA Analysis of MedTech Acquisition Corp
| ROA Ratio of MTAC rose handsomely by 1350.44 % this year. |
| ROA of MedTech Acquisition Corp is negative because of negative Income in Quarterly result ended on Jun-23. |
Other ROA Related Info of MTAC that may interest you.
MedTech Acquisition Corp Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MTAC | 11.34 | 9.5559 | 18.67 % | Shell Companies |
Defination of Return On Asset
The return on assets (ROA) is a commonly used profitability ratio that shows how effectively a company uses its assets to generate profit. more ..
ROA Related Ratios
| ReturnOnEquity | AssetTurnoverRatio |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical Return On Asset of MedTech Acquisition Corp
| Period | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|
| ROA | 27.44 | 1.89 | -0.0421 |
| Change | 1350.44 % | 4595.74 % |
FY Chart of Return On Asset of MedTech Acquisition Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)